These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32035117)

  • 1. The burden of type 2 diabetes in Europe: Current and future aspects of insulin treatment from patient and healthcare spending perspectives.
    Ceriello A; deValk HW; Guerci B; Haak T; Owens D; Canobbio M; Fritzen K; Stautner C; Schnell O
    Diabetes Res Clin Pract; 2020 Mar; 161():108053. PubMed ID: 32035117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus evidence-based guidelines for insulin initiation, optimization and continuation in type 2 diabetes mellitus.
    Shah S; Sharma SK; Singh P; Muruganathan A; Das AK;
    J Assoc Physicians India; 2014 Jul; 62(7 Suppl):49-54. PubMed ID: 25668937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based recommendations for insulin intensification strategies after basal insulin in type 2 diabetes.
    Ghosh S; Unnikrishnan AG; Saboo B; Kesavadev J; Aravind SR; Bajaj S; Rajput R; Seshadri K; Verma N; Gupta A; Makkar BM; Saikia M; Kale S; Damodaran S; Dengra A; Eashwar TKM; Maheshwari A; Pendsey S; Phatak SR; Sharma SK; Singh SK; Ramachandran A; Zargar AH; Joshi SR; Sadikot SM
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S507-S521. PubMed ID: 28433618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin therapy in type 2 diabetes.
    Mudaliar S; Edelman SV
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of insulin glargine in suboptimally controlled patients with type 2 diabetes: sub-analysis of the AT.LANTUS trial comparing treatment outcomes in subjects from primary and secondary care in the UK.
    Davies M; Evans R; Storms F; Gomis R; Khunti K
    Diabetes Obes Metab; 2007 Sep; 9(5):706-13. PubMed ID: 17697063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study.
    Cariou B; Fontaine P; Eschwege E; Lièvre M; Gouet D; Huet D; Madani S; Lavigne S; Charbonnel B
    Diabetes Metab; 2015 Apr; 41(2):116-25. PubMed ID: 25465273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study.
    Eby EL; Boye KS; Lage MJ
    J Med Econ; 2013 Oct; 16(10):1231-7. PubMed ID: 23834480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre randomized controlled trial with sensor-augmented pump vs multiple daily injections in hospitalized patients with type 2 diabetes in China: Time to reach target glucose.
    Gu W; Liu Y; Chen Y; Deng W; Ran X; Chen L; Zhu D; Yang J; Shin J; Lee SW; Cordero TL; Mu Y
    Diabetes Metab; 2017 Sep; 43(4):359-363. PubMed ID: 28236571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
    Noh RM; Graveling AJ; Frier BM
    Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and trends in insulin initiation and intensification among patients with Type 2 diabetes mellitus in the Middle East and North Africa region.
    Jabbar A; Abdallah K; Hassoun A; Malek R; Senyucel C; Spaepen E; Treuer T; Bhattacharya I
    Diabetes Res Clin Pract; 2019 Mar; 149():18-26. PubMed ID: 30653994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Pump Therapy for Patients With Type 2 Diabetes Mellitus: Evidence, Current Barriers, and New Technologies.
    Freckmann G; Buck S; Waldenmaier D; Kulzer B; Schnell O; Gelchsheimer U; Ziegler R; Heinemann L
    J Diabetes Sci Technol; 2021 Jul; 15(4):901-915. PubMed ID: 32476471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlates of basal insulin persistence among insulin-naïve people with type 2 diabetes: results from a multinational survey.
    Peyrot M; Perez-Nieves M; Ivanova J; Cao D; Schmerold L; Kalirai S; Hadjiyianni I
    Curr Med Res Opin; 2017 Oct; 33(10):1843-1851. PubMed ID: 28604112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of hypoglycaemia on patient-reported outcomes from a global, 24-country study of 27,585 people with type 1 and insulin-treated type 2 diabetes.
    Khunti K; Alsifri S; Aronson R; Cigrovski Berković M; Enters-Weijnen C; Forsén T; Galstyan G; Geelhoed-Duijvestijn P; Goldfracht M; Gydesen H; Kapur R; Lalic N; Ludvik B; Moberg E; Pedersen-Bjergaard U; Ramachandran A;
    Diabetes Res Clin Pract; 2017 Aug; 130():121-129. PubMed ID: 28602812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of pramlintide added to mealtime insulin in patients with type 1 or type 2 diabetes: a large observational study.
    Pencek R; Roddy T; Peters Y; De Young MB; Herrmann K; Meller L; Nguyen H; Chen S; Lutz K
    Diabetes Obes Metab; 2010 Jun; 12(6):548-51. PubMed ID: 20518811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The introduction of insulin in type 2 diabetes mellitus.
    Wong J; Tabet E
    Aust Fam Physician; 2015 May; 44(5):278-83. PubMed ID: 26042399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin therapy in elderly patients with type 2 diabetes: the role of insulin glargine.
    Janka HU
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():35-41. PubMed ID: 18577155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin glargine and its role in glycaemic management of Type 2 diabetes.
    Elrishi MA; Jarvis J; Khunti K; Davies MJ
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1099-110. PubMed ID: 18680444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Patient Acceptance and Adherence Toward Insulin.
    Riddle M; Peters A; Funnell M
    Postgrad Med; 2016 Oct; 128 Suppl 1():11-20. PubMed ID: 27109558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.